Back

A digital tool developed by multidisciplinary physicians to improve prostate cancer management: cardiovascular prevention and drug-drug interaction

19 June 2026 (10:45 - 11:30)
Organised by: Logo
Congress Presentation Part of: Preventing cardiotoxicity Stratification, Prevention and Monitoring Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Doctor Elvire Mervoyer

West cancer institute, Nantes (France)

5 More presentations in this session

Presentation thumbnail
Effects of tailored exercise prescription on cardiorespiratory fitness in breast cancer survivors: findings from the munich cardio-oncology-exercise retrospective registry
Ms L. Kuehberger (Munich, DE)
Abstract Slides
Presentation thumbnail
Insufficient control of classical atherosclerotic risk factors in patients with non-metastatic breast cancer referred for anticancer therapy
Doctor S. Medrek (Brzozow, PL)
Abstract Slides
Presentation thumbnail
Exploring the relationship between oral health and cancer therapy related cardiac dysfunction in HER2-positive breast cancer patients
Doctor A. Basuoni (Muscat, OM)
Abstract Slides
Presentation thumbnail
Effect of primary prevention on major adverse cardiac event in breast cancer patients on cytotoxic chemotherapy
Mr A. Kawatkar (Pasadena, US)
Abstract Slides
Presentation thumbnail
Efficacy of beta-blockers in preventing anthracycline-induced cardiotoxicity: updated meta-analysis of randomized controlled trials
Doctor P. Silva De Marco (Sao Jose do Rio Preto, BR)
Abstract Slides

Access the full session

Session thumbnail
Preventing cardiotoxicity

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 10:45 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources